75 related articles for article (PubMed ID: 11149627)
1. PCR-SSCP analysis of human adrenocortical adenomas: absence of K-ras gene mutations.
Ocker M; Sachse R; Rico A; Hensen J
Exp Clin Endocrinol Diabetes; 2000; 108(8):513-4. PubMed ID: 11149627
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53 in adrenocortical tumours: clinicopathological correlations.
McNicol AM; Nolan CE; Struthers AJ; Farquharson MA; Hermans J; Haak HR
J Pathol; 1997 Feb; 181(2):146-52. PubMed ID: 9120717
[TBL] [Abstract][Full Text] [Related]
3. [K-ras gene mutations in adenomas from familial adenomatous polyposis].
Ohki S; Onda M; Nomizu T; Tsuchiya A; Ami H; Fukushima T; Takita K; Kanazawa M; Watanabe F; Andoh Y; Yoshida T; Abe R
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():154-8. PubMed ID: 8678560
[TBL] [Abstract][Full Text] [Related]
4. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
5. Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient.
Zauber NP; Sabbath-Solitare M; Marotta SP; Zauber AG; Bishop DT
J Pathol; 2001 Mar; 193(3):303-9. PubMed ID: 11241408
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
7. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum.
Garrett AP; Ng SW; Muto MG; Welch WR; Bell DA; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Apr; 77(1):105-11. PubMed ID: 10739698
[TBL] [Abstract][Full Text] [Related]
8. Effect of polymer matrix and glycerol on rapid single-strand conformation polymorphism analysis by capillary and microchip electrophoresis for detection of mutations in K-ras gene.
Endo Y; Zhang L; Katashima R; Itakura M; Doherty EA; Barron AE; Baba Y
Electrophoresis; 2005 Sep; 26(17):3380-6. PubMed ID: 16097023
[TBL] [Abstract][Full Text] [Related]
9. Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype.
Kim TY; Bang YJ; Kim WS; Kang SH; Lee KU; Choe KJ; Kim NK
Anticancer Res; 1997; 17(2B):1335-9. PubMed ID: 9137494
[TBL] [Abstract][Full Text] [Related]
10. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
11. Mutations of K-ras oncogene in human adrenal tumours in Taiwan.
Lin SR; Tsai JH; Yang YC; Lee SC
Br J Cancer; 1998 Apr; 77(7):1060-5. PubMed ID: 9569040
[TBL] [Abstract][Full Text] [Related]
12. [Detection of K-ras oncogene mutations in human lung cancer by PCR-SSCP-DNA direct sequencing].
Fang Q; Li X; Li J; Liang S
Wei Sheng Yan Jiu; 1998 Jan; 27(1):6-8. PubMed ID: 10682630
[TBL] [Abstract][Full Text] [Related]
13. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
Minamoto T; Mai M; Ronai Z
Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
[TBL] [Abstract][Full Text] [Related]
14. Optimization of restriction fragment length polymorphism and single strand conformation polymorphism analysis for the detection of point mutations of ras oncogenes in paraffin-embedded tissues.
Weise B; Ghebremedhin E; Zschunke F; Radzun HJ
Gen Diagn Pathol; 1996 Jun; 142(1):45-52. PubMed ID: 8793486
[TBL] [Abstract][Full Text] [Related]
15. Decreased GTPase activity of K-ras mutants deriving from human functional adrenocortical tumours.
Lin SR; Hsu CH; Tsai JH; Wang JY; Hsieh TJ; Wu CH
Br J Cancer; 2000 Mar; 82(5):1035-40. PubMed ID: 10737386
[TBL] [Abstract][Full Text] [Related]
16. K-ras and p53 gene mutations in colorectal cancer in 57 Japanese patients.
Onda M; Abe R; Tsuchiya A; Fukushima T; Ando Y; Yoshida T
Fukushima J Med Sci; 1997 Jun; 43(1):29-39. PubMed ID: 9431782
[TBL] [Abstract][Full Text] [Related]
17. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.
Nikiforov YE; Nikiforova MN; Gnepp DR; Fagin JA
Oncogene; 1996 Aug; 13(4):687-93. PubMed ID: 8761289
[TBL] [Abstract][Full Text] [Related]
19. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
[TBL] [Abstract][Full Text] [Related]
20. MEN1 gene mutation analysis of sporadic adrenocortical lesions.
Görtz B; Roth J; Speel EJ; Krähenmann A; De Krijger RR; Matias-Guiu X; Muletta-Feurer S; Rütmann K; Saremaslani P; Heitz PU; Komminoth P
Int J Cancer; 1999 Jan; 80(3):373-9. PubMed ID: 9935177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
